High-priced drugs stretching rich nations' health budgets: OECD
London
SPECIALITY medicines for which pharmaceutical companies demand high prices are straining wealthy nations' health budgets, the OECD (Organisation for Economic Co-operation and Development) said on Wednesday, with drugs accounting for some 20 per cent of all health spending.
Across the 33 OECD countries, pharmaceutical spending reached US$800 billion in 2013, and new drugs and rising demand are likely to continue to push that level higher, the OECD said.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
100 years on, SICCI to focus on internationalisation, digitalisation and sustainability
Microsoft bets big on South-east Asia, pledges billions in AI and cloud investments
Putin plans to meet Xi in China days after his new term starts
Biden vetoes bid to repeal US labour board rule on contract, franchise workers
Economic leaders of South Korea, Japan, China say FX volatility is a risk
US automakers win extension on use of Chinese graphite in EV tax credits